Search Login Register

Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis) Summary

Description: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.

Also Known As: Hypersensitivity Angiitis; Vasculitis, Leukocytoclastic, Cutaneous; Allergic Cutaneous Angiitis; Allergic Cutaneous Vasculitis; Angiitis, Allergic Cutaneous Show All >>

Networked: 163 relevant articles (3 outcomes, 4 trials/studies) for this Disease

Key Drugs and Agents for Cutaneous Leukocytoclastic Vasculitis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Colchicine : 2 outcomes in 2 results : FDA 13 Generic
  2. Emollients : 1 outcome in 1 result : IBA
  3. Cortisone : 1 outcome in 1 result : IBA
  4. Erythema elevatum diutinum : 2 studies in 24 results : IBA
  5. Immunoglobulins (Immunoglobulin) : 1 study in 1 result : IBA
  6. Glyburide (Glibenclamide) : 1 study in 1 result : FDA 20 Generic
  7. glucuronyl glucosamine glycan sulfate (Vessel) : 17 results : IBA
  8. Immunoglobulin A (IgA) : 12 results : IBA
  9. Antigen-Antibody Complex (Immune Complex) : 12 results : IBA
  10. Streptokinase : 5 results : FDA 1
Show All >>

Diseases Related to Cutaneous Leukocytoclastic Vasculitis

  1. Systemic Vasculitis
  2. Vasculitis (Vasculitides)
  3. Purpura
  4. Polyarteritis Nodosa (Periarteritis Nodosa)
  5. Infection
Show All >>

Key Therapies for Cutaneous Leukocytoclastic Vasculitis

Efficacy Chart >>
  1. Immunotherapy : 2 results
  2. Transplants (Transplant) : 1 result
  3. Heart Transplantation (Grafting, Heart) : 1 result
  4. Thrombolytic Therapy : 1 result
  5. Plasma Exchange : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.